HCPCS Level II code L8682 designates an implantable neurostimulator radiofrequency receiver, a hardware component of implantable neurostimulation systems used to receive radiofrequency signals for powering or controlling implanted stimulators. Nationally, this device-level code matters for durable medical equipment and implantable device billing, inventory management, and device-specific reimbursement pathways that affect hospitals, ambulatory surgery centers, and durable medical equipment suppliers.

Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical role and typical sites of service, followed by national benchmarking context where available. The publication outlines common modifiers associated with device billing, notes where input data are missing, and highlights related administrative considerations such as supply versus device classification and billing lines for implantable components.

This summary prepares clinicians, billing professionals, and policy analysts to interpret how L8682 is used in claims and claim lines, what to expect in payer coverage conversations, and which operational areas — procurement, coding, and facility billing — are most impacted by implantable neurostimulator receiver devices.